Proteinase-activated receptors.

By S. Macfarlane, M. J. Seatter, T. Kanke, Gary D. Hunter, R. Plevin. Pharmacological Reviews, 2001

1,206 citations recorded by the source corpus.

Subfields: Cancer Research, Genetics, Hematology

View Paper: https://www.semanticscholar.org/paper/796a8f2b745f5e7f46f5fc14a06ed935c79999e6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. R. Khalil
2. Xi Wang
3. V. Ossovskaya
4. N. Bunnett

In Genetics

1. Xi Wang
2. R. Khalil
3. V. Ossovskaya
4. N. Bunnett

In Hematology

1. R. Khalil
2. Xi Wang
3. V. Ossovskaya
4. N. Bunnett

Citations in the corpus

• Protease-activated receptors: contribution to physiology and disease. (2004, background): “The mechanisms of PAR1 and PAR2 signaling have been extensively investigated and reviewed (89, 182).”
• Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. (2018, background): “A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript in MMP-1 protein level in the great saphenous vein, and an increase in the levels of MMP-1 and MMP-13 in the proximal versus distal segments of varicose veins, with no change in MMP mRNA expression, suggesting that the i”
• Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. (2008, background): “MMPs may also stimulate protease-activated receptors (PARs) and activate signaling pathways that could lead to blockade of VSM Ca2+ channels [26].”